ASK CAPITAL INVESTMENT MANAGERS, LLC’s AbbVie ABBV Stock Holding History

ASK CAPITAL INVESTMENT MANAGERS, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.7M	Buy	+21,800	New	+$5.59M	5.87%	2

Other funds holding ABBV

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

ASK CAPITAL INVESTMENT MANAGERS, LLC's ABBV Position: Q3 2026 in Review

ASK CAPITAL INVESTMENT MANAGERS, LLC opened a new position in AbbVie (ABBV) in Q3 2026: 21,800 shares worth $5.7M. The stake represents 5.87% of the portfolio and ranks #2 among its holdings.

541 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

ASK CAPITAL INVESTMENT MANAGERS, LLC held 21,800 shares of AbbVie worth $5.7M as of Q3 2026.
AbbVie was a new ASK CAPITAL INVESTMENT MANAGERS, LLC position in Q3 2026.
AbbVie made up 5.87% of ASK CAPITAL INVESTMENT MANAGERS, LLC's portfolio in Q3 2026, its #2 holding.
541 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on ASK CAPITAL INVESTMENT MANAGERS, LLC's 13F filing for Q3 2026, filed 14 Oct 2026.